Leadership
Our Science
▼
Overview
Platforms
Capabilities
Collaborations
Publications & Presentations
Our Programs
▼
Overview
Pipeline
Programs
Patients
▼
Overview
Elevating Patient Voices
Advocacy at Tenaya
Clinical Studies
Gene Therapy for Cardiomyopathies
Advocacy Partners
Investors
▼
Overview
News & Events
▼
Press Releases
Events & Presentations
Corporate Governance
▼
Governance Overview
Board of Directors
Management
Committee Composition
Financial Information
▼
SEC Filings
Quarterly Results
Stock Information
▼
Stock Quote & Chart
Analyst Coverage
IR Resources
▼
Investor FAQs
Contact IR
Email Alerts
HCP Resource Center
▼
Overview
Genetic Medicine Primer
▼
Overview
About Gene Therapy
TN-201 for
MYBPC3
– associated HCM
▼
Overview
Hypertrophic Cardiomyopathy and Genetics
How TN-201 Works
MyPEAK-1 Phase 1b/2 Clinical Trial
Tenaya’s Non-interventional Studies for
MYBPC3
HCM
Webinars
FAQ’s
TN-401 for
PKP2
– associated ARVC
▼
Overview
ARVC and Genetics
How TN-401 works
RIDGE-1 Phase 1b Clinical Trial
Tenaya’s Non-interventional Study for
PKP2
-Associated ARVC
FAQ’s
Careers at Tenaya
Contact Us
Careers at Tenaya
Contact Us
Leadership
Our Science
Platforms
Capabilities
Collaborations
Publications & Presentations
Our Programs
Pipeline
Programs
Patients
Elevating Patient Voices
Advocacy at Tenaya
Clinical Studies
Gene Therapy for Cardiomyopathies
Advocacy Partners
Investors
News & Events
Press Releases
Events & Presentations
Corporate Governance
Governance Overview
Board of Directors
Management
Committee Composition
Financial Information
SEC Filings
Quarterly Results
Stock Information
Stock Quote & Chart
Analyst Coverage
IR Resources
Investor FAQs
Contact IR
Email Alerts
HCP Resource Center
Genetic Medicine Primer
About Gene Therapy
TN-201 for
MYBPC3
– associated HCM
Hypertrophic Cardiomyopathy and Genetics
How TN-201 Works
MyPEAK-1 Phase 1b/2 Clinical Trial
Tenaya’s Non-interventional Studies for
MYBPC3
HCM
Webinars
FAQ’s
TN-401 for
PKP2
– associated ARVC
ARVC and Genetics
How TN-401 works
RIDGE-1 Phase 1b Clinical Trial
Tenaya’s Non-interventional Study for
PKP2
-Associated ARVC
FAQ’s
Career Opportunities
← Back to Careers
